Literature DB >> 16042503

Organophosphate-induced delayed polyneuropathy.

Marcello Lotti1, Angelo Moretto.   

Abstract

Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare toxicity resulting from exposure to certain organophosphorus (OP) esters. It is characterised by distal degeneration of some axons of both the peripheral and central nervous systems occurring 1-4 weeks after single or short-term exposures. Cramping muscle pain in the lower limbs, distal numbness and paraesthesiae occur, followed by progressive weakness, depression of deep tendon reflexes in the lower limbs and, in severe cases, in the upper limbs. Signs include high-stepping gait associated with bilateral foot drop and, in severe cases, quadriplegia with foot and wrist drop as well as pyramidal signs. In time, there might be significant recovery of the peripheral nerve function but, depending on the degree of pyramidal involvement, spastic ataxia may be a permanent outcome of severe OPIDP. Human and experimental data indicate that recovery is usually complete in the young. At onset, the electrophysiological changes include reduced amplitude of the compound muscle potential, increased distal latencies and normal or slightly reduced nerve conduction velocities. The progression of the disease, usually over a few days, may lead to non-excitability of the nerve with electromyographical signs of denervation. Nerve biopsies have been performed in a few cases and showed axonal degeneration with secondary demyelination. Neuropathy target esterase (NTE) is thought to be the target of OPIDP initiation. The ratio of inhibitory powers for acetylcholinesterase and NTE represents the crucial guideline for the aetiological attribution of OP-induced peripheral neuropathy. In fact, pre-marketing toxicity testing in animals selects OP insecticides with cholinergic toxicity potential much higher than that to result in OPIDP. Therefore, OPIDP may develop only after very large exposures to insecticides, causing severe cholinergic toxicity. However, this was not the case with certain triaryl phosphates that were not used as insecticides but as hydraulic fluids, lubricants and plasticisers and do not result in cholinergic toxicity. Several thousand cases of OPIDP as a result of exposure to tri-ortho-cresyl phosphate have been reported, whereas the number of cases of OPIDP as a result of OP insecticide poisoning is much lower. In this article, we mainly discuss OP pesticide poisoning, particularly when caused by chlorpyrifos, dichlorvos, isofenphos, methamidophos, mipafox, trichlorfon, trichlornat, phosphamidon/mevinphos and by certain carbamates. We also discuss case reports where neuropathies were not convincingly attributed to fenthion, malathion, omethoate/dimethoate, parathion and merphos. Finally, several observational studies on long-term, low-level exposures to OPs that sometimes reported mild, inconsistent and unexplained changes of unclear significance in peripheral nerves are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042503     DOI: 10.2165/00139709-200524010-00003

Source DB:  PubMed          Journal:  Toxicol Rev        ISSN: 1176-2551


  51 in total

Review 1.  Management of acute organophosphorus pesticide poisoning.

Authors:  Darren M Roberts; Cynthia K Aaron
Journal:  BMJ       Date:  2007-03-24

Review 2.  Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.

Authors:  Samantha J Merwin; Teresa Obis; Yanelli Nunez; Diane B Re
Journal:  Arch Toxicol       Date:  2017-01-09       Impact factor: 5.153

3.  Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice.

Authors:  Haley E Speed; Cory A Blaiss; Ahleum Kim; Michael E Haws; Neal R Melvin; Michael Jennings; Amelia J Eisch; Craig M Powell
Journal:  Toxicol Sci       Date:  2011-09-26       Impact factor: 4.849

4.  Preparation and characterization of diethoxy- and monoethoxy phosphylated ('aged') serine haptens and use in the production of monoclonal antibodies.

Authors:  Yamina Belabassi; Chih-Kai Chao; Ryan Holly; Kathleen M George; Jon O Nagy; Charles M Thompson
Journal:  Chem Biol Interact       Date:  2014-09-26       Impact factor: 5.192

5.  Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.

Authors:  Nichole D Hein; Jeanne A Stuckey; Shirley R Rainier; John K Fink; Rudy J Richardson
Journal:  Toxicol Lett       Date:  2010-04-09       Impact factor: 4.372

6.  Occupational exposure to neurotoxic substances in Asian countries - challenges and approaches.

Authors:  Monika Meyer-Baron; Eun A Kim; Iman Nuwayhid; Gaku Ichihara; Seong-Kyu Kang
Journal:  Neurotoxicology       Date:  2011-12-20       Impact factor: 4.294

Review 7.  Animal models of peripheral neuropathy due to environmental toxicants.

Authors:  Deepa B Rao; Bernard S Jortner; Robert C Sills
Journal:  ILAR J       Date:  2014

8.  Repeated exposures to diisopropylfluorophosphate result in impairments of sustained attention and persistent alterations of inhibitory response control in rats.

Authors:  Alvin V Terry; Patrick M Callahan; Wayne D Beck; Leah Vandenhuerk; Samantha Sinha; Kristy Bouchard; Rose Schade; Jennifer L Waller
Journal:  Neurotoxicol Teratol       Date:  2014-05-10       Impact factor: 3.763

9.  Delayed neuropathy due to organophosphate insecticide injection in an attempt to commit suicide.

Authors:  Selma Sönmez Ergün; Kahraman Oztürk; Ozlem Su; Esra Başar Gürsoy; Işil Uğurad; Gökşen Yüksel
Journal:  Hand (N Y)       Date:  2008-08-26

10.  Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Authors:  Snjezana Zaja-Milatovic; Ramesh C Gupta; Michael Aschner; Dejan Milatovic
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.